Braeburn bags $110M in launch cash as PDUFA date rolls up; Endo subpoenaed for documents on opioid painkillers
→ After failing to get a liftoff on Nasdaq last year, Braeburn has raised $110 million in mezzanine financing to back the prospective launch …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.